martes, 11 de enero de 2011

HIV/AIDS Clinical Care for January 10, 2011

Buenos días este es una copia de los temarios recibidos sobre VIH/SIDA, publicados en Journal Watch, que quiero compartir con ustedes.

Cada uno de los artículos tienen sus referencias para que puedan buscarlos y leerlos. 


Saludos 


Dr. Carlos Erazo

 


"SUMMARY AND COMMENT
January 10, 2011 | Rajesh T. Gandhi, MD
An HIV-infected man who underwent stem-cell transplantation for leukemia continues to be free of the virus more than 3.5 years later, without any antiretroviral therapy.
Reviewing: Allers K et al. Blood 2010 Dec 8;
DRUG WATCH
January 10, 2011 | Paul E. Sax, MD
Etravirine is now available in a 200-mg tablet, darunavir is approved for once-daily dosing in some treatment-experienced patients, and the d4T label no longer calls for dose reduction to prevent toxicity.
SUMMARY AND COMMENT
January 10, 2011 | Abigail Zuger, MD
Echocardiographic abnormalities were prevalent but mostly mild in a cohort of HIV-infected patients, the majority of whom were receiving ART.
Reviewing: Mondy K et al. Clin Infect Dis 2011 Feb 1; 52:378
SUMMARY AND COMMENT
January 10, 2011 | Rajesh T. Gandhi, MD
The extent to which individual antiretrovirals penetrate the central nervous system may influence whether those drugs improve cognitive function, but the jury's still out.
Reviewing: Smurzynski M et al. AIDS 2010 Nov 30;""




No hay comentarios:

Publicar un comentario